The Exa PACS/RIS platform reportedly combines AI-enabled worklist navigation tools with advances in multiplanar functionality and 3D-generated image segmentation.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
-
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
-
Breast MRI-Based Radiomics May Reduce Overtreatment of DCIS
New multicenter research suggests that radiomic features derived from breast MRI may enhance prognostic capabilities with disease upstaging for ductal carcinoma in situ (DCIS).
-
FDA Clears AZchest AI Software for New CXR Applications
The AI-powered AZchest CXR software reportedly offers 93.79 percent sensitivity and a 98.57 percent AUC for pneumothorax.
-
Are CT and MRI-Derived LI-RADS Assessments Effective for Detecting HCC in Cases of Non-Cirrhotic Chronic Hepatitis C?
LI-RADS category 5 (LR-5) assessment had an 11 percent higher AUC for detecting hepatocellular carcinoma (HCC) in patients with non-cirrhotic chronic hepatitis C (CHC) in comparison to those with cirrhotic CHC.
-
Receiving Thanks and Being Thankful in Radiology
How should you respond when being thanked broadly for the work you do in radiology?
-
Interventional Radiology-Led Study Shows Significant Limb Salvage Benefits with Transcatheter Arterialization
For patients with no-option chronic limb-threatening ischemia (CLTI), transcatheter arterialization provided over a 25 percent higher amputation-free survival rate over standard medical management at one year, according to research presented at the Society of Interventional Radiology (SIR) Annual Scientific Meeting.
-
Diagnostic Imaging's Weekly Scan: March 23 — March 29
Catch up on the top radiology content of the past week.
-
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).